The role of immunotherapy in childhood asthma

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

While immunotherapy has been widely used to treat children with asthma, many issues remain to be resolved concerning the safety and efficacy of immunotherapy in asthmatic children. Studies have suggested that immunotherapy should reduce the pulmonary inflammatory response characteristic of asthma, however, recent clinical trials have often shown little benefit from immunotherapy in children with asthma. One of the most interesting questions is whether the early institution of immunotherapy in high-risk children might reduce the risk of developing asthma. Given the many unresolved issues concerning immunotherapy, as an adjunct to the treatment of asthma, physicians must carefully weigh all the potential risks and benefits for each patient.

Original languageEnglish (US)
Pages (from-to)199-209
Number of pages11
JournalImmunology and Allergy Clinics of North America
Volume18
Issue number1
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Immunotherapy
Asthma
Clinical Trials
Physicians
Safety
Lung

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The role of immunotherapy in childhood asthma. / Ownby, Dennis Randall.

In: Immunology and Allergy Clinics of North America, Vol. 18, No. 1, 01.01.1998, p. 199-209.

Research output: Contribution to journalArticle

@article{23cba1f8e76446779f882c9d29009d8a,
title = "The role of immunotherapy in childhood asthma",
abstract = "While immunotherapy has been widely used to treat children with asthma, many issues remain to be resolved concerning the safety and efficacy of immunotherapy in asthmatic children. Studies have suggested that immunotherapy should reduce the pulmonary inflammatory response characteristic of asthma, however, recent clinical trials have often shown little benefit from immunotherapy in children with asthma. One of the most interesting questions is whether the early institution of immunotherapy in high-risk children might reduce the risk of developing asthma. Given the many unresolved issues concerning immunotherapy, as an adjunct to the treatment of asthma, physicians must carefully weigh all the potential risks and benefits for each patient.",
author = "Ownby, {Dennis Randall}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0889-8561(05)70356-8",
language = "English (US)",
volume = "18",
pages = "199--209",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The role of immunotherapy in childhood asthma

AU - Ownby, Dennis Randall

PY - 1998/1/1

Y1 - 1998/1/1

N2 - While immunotherapy has been widely used to treat children with asthma, many issues remain to be resolved concerning the safety and efficacy of immunotherapy in asthmatic children. Studies have suggested that immunotherapy should reduce the pulmonary inflammatory response characteristic of asthma, however, recent clinical trials have often shown little benefit from immunotherapy in children with asthma. One of the most interesting questions is whether the early institution of immunotherapy in high-risk children might reduce the risk of developing asthma. Given the many unresolved issues concerning immunotherapy, as an adjunct to the treatment of asthma, physicians must carefully weigh all the potential risks and benefits for each patient.

AB - While immunotherapy has been widely used to treat children with asthma, many issues remain to be resolved concerning the safety and efficacy of immunotherapy in asthmatic children. Studies have suggested that immunotherapy should reduce the pulmonary inflammatory response characteristic of asthma, however, recent clinical trials have often shown little benefit from immunotherapy in children with asthma. One of the most interesting questions is whether the early institution of immunotherapy in high-risk children might reduce the risk of developing asthma. Given the many unresolved issues concerning immunotherapy, as an adjunct to the treatment of asthma, physicians must carefully weigh all the potential risks and benefits for each patient.

UR - http://www.scopus.com/inward/record.url?scp=0031885803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031885803&partnerID=8YFLogxK

U2 - 10.1016/S0889-8561(05)70356-8

DO - 10.1016/S0889-8561(05)70356-8

M3 - Article

AN - SCOPUS:0031885803

VL - 18

SP - 199

EP - 209

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 1

ER -